Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-01-15 4:14 pm Purchase | 2025-01-08 | 13G | Tenax Therapeutics, Inc. TENX | Dellora Investments Master Fund LP | 351,071 10.300% | 116,278 (+49.52%) | Filing History |
2024-12-05 1:47 pm Purchase | 2024-11-27 | 13G | Tenax Therapeutics, Inc. TENX | Dellora Investments Master Fund LP | 234,793 6.900% | 234,793 (New Position) | Filing History |
2024-11-14 7:14 pm Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Lind Global Fund II LP | 375,000 9.900% | 375,000 (New Position) | Filing History |
2024-11-14 12:39 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | JANUS HENDERSON GROUP PLC JHG | 359,848 10.000% | 0 (Unchanged) | Filing History |
2024-11-14 12:21 pm Sale | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | CVI Investments, Inc. | 0 0.000% | -204,027 (Position Closed) | Filing History |
2024-11-13 5:35 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 0 (Unchanged) | Filing History |
2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Adage Capital Management L.P. | 369,097 9.990% | 369,097 (New Position) | Filing History |
2024-09-10 5:19 pm Purchase | 2024-08-31 | 13G | Tenax Therapeutics, Inc. TENX | T. Rowe Price Associates, Inc. | 3,750,000 19.990% | 3,750,000 (New Position) | Filing History |
2024-08-19 6:48 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | BIOTECHNOLOGY VALUE FUND L P | 340,660 9.990% | 340,660 (New Position) | Filing History |
2024-08-19 4:15 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | Venrock Healthcare Capital Partners III L.P. | 355,224 9.990% | 355,224 (New Position) | Filing History |
2024-08-15 4:19 pm Purchase | 2024-08-06 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 372,797 (New Position) | Filing History |
2024-08-14 6:47 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | Vivo Opportunity Fund Holdings L.P. | 6,249,990 9.990% | 6,249,990 (New Position) | Filing History |
2024-08-14 3:19 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | JANUS HENDERSON GROUP PLC JHG | 359,848 9.900% | 359,848 (New Position) | Filing History |
2024-02-20 4:01 pm Purchase | 2024-02-08 | 13G | Tenax Therapeutics, Inc. TENX | S.H.N. Financial Investments Ltd. | 107,000 5.600% | 107,000 (New Position) | Filing History |
2024-02-16 11:28 am Purchase | 2024-02-08 | 13G | Tenax Therapeutics, Inc. TENX | CVI Investments, Inc. | 204,027 9.900% | 204,027 (New Position) | Filing History |
2024-02-15 7:36 pm Purchase | 2024-02-12 | 13G | Tenet Healthcare Corporation THC | Lind Global Fund II LP | 71,500 9.900% | 71,500 (New Position) | Filing History |
2024-02-14 2:58 pm Purchase | 2023-12-31 | 13G | Tenax Therapeutics, Inc. TENX | ARMISTICE CAPITAL LLC | 17,241 0.070% | 17,241 (New Position) | Filing History |
2023-02-14 1:36 pm Purchase | 2022-12-31 | 13G | Tenax Therapeutics, Inc. TENX | ARMISTICE CAPITAL LLC | 62,009 9.990% | 29,841 (+92.76%) | Filing History |
2023-02-13 06:39 am Purchase | 2023-02-03 | 13G | Tenax Therapeutics, Inc. TENX | Mitchell P. Kopin | 5,997 4.990% | 5,997 (New Position) | Filing History |
2023-02-09 4:31 pm Unchanged | 2023-02-07 | 13D | Tenax Therapeutics, Inc. TENX | Rich Stuart | 2,691 2.320% | 0 (Unchanged) | Filing History |